J. B. CHEMICALS & PHARMACEUTICALS LIMITED

J. B. Chemicals & Pharmaceuticals Limited NSE India S.E.

JBCHEPHARM

INE572A01036

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-07-15 am EDT			5-day change	1st Jan Change
1,785 ^INR	+2.00%		+2.41%	+9.84%

Jul. 09	J. B. Chemicals & Pharmaceuticals Limited Appoints Arun Duggal, Non-Executive Independent Director, as the Non-Executive Chairman	CI
Jul. 05	J. B. Chemicals & Pharmaceuticals Limited Approves the Appointment of Arun Duggal as Non-Executive Independent Director	CI

J B Chemicals and Pharmaceuticals : Notice of Board Meeting

January 06, 2016 at 04:35 am EST

302f198e-ef35-4ad7-8769-584c2029f0e9.pdf

Regd. Office : Neelam Centre, 'B' Wing, 4th Floor, Hind Cycle Road, Worli, Mumbai 400 030.

Phone: 022-24822222/24930918 Fax : 022 - 2493 0534/ 2493 9633

CIN : L24390MH1976PLC019380 Website: www.jbcpl.com

E-mail : secretarial@jbcpl.com

NOTICE

Notice is hereby given, pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, that meeting of the board of directors of the company will be held on Wednesday, February 3, 2016, inter alia, to consider and approve unaudited financial results for the quarter ended on December 31, 2015.

For J. B. Chemicals & Pharmaceuticals Limited

Sd/-

Place: Mumbai M. C. Mehta

Date : January 6, 2016 Company Secretary & Vice President-Compliance

JB Chemicals & Pharmaceuticals Ltd. issued this content on 2016-01-06 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-06 09:34:10 UTC

Original Document: http://www.jbcpl.com/download/196

Latest news about J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited Appoints Arun Duggal, Non-Executive Independent Director, as the Non-Executive Chairman	Jul. 09	CI
J. B. Chemicals & Pharmaceuticals Limited Approves the Appointment of Arun Duggal as Non-Executive Independent Director	Jul. 05	CI
Jefferies Adjusts JB Chemicals & Pharmaceuticals' Price Target to INR2,060 From INR2,000, Keeps at Buy	May. 22	MT
Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q4 2024 Earnings Call, May 21, 2024	May. 21
J. B. Chemicals & Pharmaceuticals Seeks Acquisition Opportunities	May. 19	CI
J. B. Chemicals & Pharmaceuticals Limited Recommends Final Dividend for the Year 2023-2024	May. 17	CI
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 17	CI
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 17	CI
KKR to buy India's Healthium Medtech at $839 million valuation, sources say	May. 06	RE
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Office of the Commissioner, GST and Central Excise, Vadodara	Apr. 30	CI
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Joint Commissioner State Tax, Lucknow II, Lucknow	Apr. 26	CI
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director	Apr. 08	CI
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Assessment Unit, Income Tax Department	Mar. 22	CI
J. B. Chemicals & Pharmaceuticals Limited Announces Demise of Ranjit Shahani, Chairman and Non-Executive, Independent Director	Mar. 09	CI
KKR Reportedly Considers Selling Controlling Stake in JB Pharma	Feb. 28	CI
Jefferies Adjusts JB Chemicals & Pharmaceuticals' Price Target to INR2,000 From INR1,970, Keeps at Buy	Feb. 08	MT
JB Chemicals' Consolidated Profit Climbs in Fiscal Q3; Shares Jump 4%	Feb. 07	MT
J.B. Pharma Seeks Acquisitions	Feb. 07	CI
Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 07, 2024	Feb. 07
J. B. Chemicals & Pharmaceuticals Appoints CFO	Feb. 06	MT
JB Chemicals Names CFO	Feb. 06	MT
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand	Feb. 06	RE
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 06	CI
J. B. Chemicals & Pharmaceuticals Limited Appoints Narayan Saraf as the Chief Financial Officer, with Effect from February 23, 2024	Feb. 06	CI
J. B. Chemicals & Pharmaceuticals Limited Declares Interim Dividend for Financial Year 2023-24	Feb. 06	CI

Chart J. B. Chemicals & Pharmaceuticals Limited

Duration

Period

Chart J. B. Chemicals & Pharmaceuticals Limited

More charts

Company Profile

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.

Sector

Pharmaceuticals

Calendar

2024-08-07 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for J. B. Chemicals & Pharmaceuticals Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,784 INR

Average target price

1,975 INR

Spread / Average Target

+10.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+63.05%	854B
NOVO NORDISK A/S	+39.42%	636B
JOHNSON & JOHNSON	-4.78%	361B
MERCK & CO., INC.	+17.52%	324B
ABBVIE INC.	+8.43%	301B
ASTRAZENECA PLC	+14.19%	247B
ROCHE HOLDING AG	+5.81%	230B
NOVARTIS AG	+16.77%	228B
AMGEN INC.	+14.63%	177B

Other Pharmaceuticals

J. B. Chemicals & Pharmaceuticals Limited NSE India S.E.

Equities

JBCHEPHARM

INE572A01036

Pharmaceuticals

J B Chemicals and Pharmaceuticals : Notice of Board Meeting

EPS Revisions